Abstract
Assessment of hepatic function is based on bothliver blood tests and functional tests, the extensiveapplication of which is still controversial. The aim ofthis study was to evaluate the clinical utility of a few selected tests as discriminatory andprognostic indexes: serum albumin, pseudocholinesterase,prothrombin time, as well as galactose eliminationcapacity and hepatic sorbitol clearance. Two separate studies were performed: Study I to investigatehow well these tests assessed severity, and Study II toevaluate their prognostic value. A total of 128consecutive cirrhotic patients classified according to the Child-Pugh score were included in StudyI; Study II was carried out on 47 of these 128 during atwo-year follow-up period. Pairwise correlations betweenall tests and Child-Pugh score yielded higher significant values for liver blood tests thanfor the functional ones. In Study I functional testssuch as galactose elimination capacity and hepaticsorbitol clearance did not appear to be better than conventional biochemical tests indiscriminating clinical severity of cirrhotic patients,as defined by Child-Pugh classification. Results ofStudy II confirmed that in severe liver cirrhosisChildPugh score remains the best method for medium- andlong-term prognosis and for planning livertransplantation. Functional tests should be reserved fordefining the residual functioning liver mass or forstudies about functional liver plasma flow.
Similar content being viewed by others
REFERENCES
Christensen E: Prognostic models in chronic liver disease: Validity, use fulness and future role. J Hepatol 26:1414-1424, 1997
McIntyre N: The limitations of conventional liver function tests. Semin Liver Dis 3:265-274, 1983
Branch RA: Drugs as indicators of hepatic function. Hepatology 2:97-105, 1982
Rothschild MA, Oratz M, Schreiber SS: Serum albumin. Hepatology 8:385-401, 1988
Gluud C, Henriksen JH, Nielsen G: Prognostic indicators in alcoholic cirrhotic men. Hepatology 8:222-227, 1988
Albers I, Hartmann H, Bircher J, Creutzfeldt W: Superiority of the Child-Pugh classification to quantitative liver function tests in assessing prognosis of liver cirrhosis. Scand J Gastroenterol 24:269-276, 1989
Spector I, Corn M: Laboratory tests of hemostasis. The relation to hemorrhage in liver disease. Arch Intern Med 119:577-82, 1967
Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N: Changes of laboratory variables with time in cirrhosis. Prognostic and therapeutic significance. Hepatology 3:843-853, 1985
Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand 175:281-289, 1964
Tygstrup N, Winkler K: Kinetics of galactose elimination. Acta Physiol Scand 32:354-362, 1954
Molino G, Cavanna A, Avagnina P, Ballarè M, Torchio M. The hepatic clearance of D-sorbitol: A non-invasive test for evaluating the functional liver plasma flow. Dig Dis Sci 32:753-758, 1987
Winkler K, Keiding S, Tygstrup N: Clearance as a quantitative measure of liver function. In The Liver. Quantitative Aspects of Structure and Function. G Paumgartner, R Preising (eds). 1973, pp 144-155
Molino G, Avagnina P, Cavanna A, Ballarè M, Torchio M, Bona B, Belforte G: Sorbitol clearance: a parameter reflecting liver plasma flow in the rat. Res Commun Chem Pathol Pharmacol 1:119-132, 1986
Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J: Steady state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroente rology 95:749-759, 1988
Molino G, Ballarè M, Torchio M, Niro AG, Aurucci PE, Grosso M, Fava C: Combined evaluation of total and functional plasma flows and intrahepatic shunting. Dig Dis Sci 36:1189-1196, 1991
Molino G, Avagnina P, Belforte G, Bircher J: Assessment of the hepatic circulation in humans: New concepts based on evidence derived from a D-sorbitol clearance method. J Lab Clin Med 131:393-405, 1998
Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, Tygstrup N: Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 4:430-435, 1984
Child CG III, Turcotte JG: Surgery and portal hypertension. In The Liver and Portal Hypertension. CG Child (ed). Philadelphia, Saunders, 1964, pp 1-85
Bergme yer HU, Gruber W, Guttmann I: D-Sorbitol. In Methods of Enzymatic Analysis. HU Bergmeyer (ed). New York, Verlag Chemie, 1975, pp 1323-1330
Cox DR: Regression models and life tables (with discussion). J R Stat (Seri B) 34:187-220, 1972
Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, Capuano G, Muraca M, Marchesini G, Bernardi M, Marenco G, Molino G, Rossaro L, Solinas A, Ascione A, AISF Group for the Study of Liver Transplantation: Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. J Hepatol 25:474-480, 1996
Merkel C, Marchesini G, Fabbri A, Bianco S, Bianchi S, Enzo E, Sacerdoti D, Zoli M, Gatta A: The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death. Hepatology 24:820-823, 1996
Rights and permissions
About this article
Cite this article
Garello, E., Battista, S., Bar, F. et al. Evaluation of Hepatic Function in Liver Cirrhosis (Clinical Utility of Galactose Elimination Capacity, Hepatic Clearance of D-Sorbitol, and Laboratory Investigations). Dig Dis Sci 44, 782–788 (1999). https://doi.org/10.1023/A:1026678228967
Issue Date:
DOI: https://doi.org/10.1023/A:1026678228967